N4 Pharma (0GO) Financial Statements
N4 Pharma Financial Overview
N4 Pharma's market cap is currently $16.96M. The company's EPS TTM is $-0.00; its P/E ratio is -7.19; N4 Pharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 7.26K | $ 7.28K | $ 1.95K | $ 0.00 | $ 0.00 |
| Gross Profit | $ 7.26K | $ 7.28K | $ 1.95K | $ 0.00 | $ 0.00 |
| Operating Income | $ -1.10M | $ -1.22M | $ -1.43M | $ -1.19M | $ -1.84M |
| EBITDA | $ -1.10M | $ -1.22M | $ -1.33M | $ -1.19M | $ -1.84M |
| Net Income | $ -1.21M | $ -1.06M | $ -1.27M | $ -1.03M | $ -1.54M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.08M | $ 625.97K | $ 1.03M | $ 1.92M | $ 1.78M |
| Total Assets | $ 1.17M | $ 775.77K | $ 1.28M | $ 2.17M | $ 2.34M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -1.08M | $ -625.97K | $ -1.03M | $ -1.92M | $ -1.78M |
| Total Liabilities | $ 97.96K | $ 124.37K | $ 81.73K | $ 77.89K | $ 212.73K |
| Stockholders' Equity | $ 1.07M | $ 647.65K | $ 1.13M | $ 2.09M | $ 2.13M |
| Cash Flow | |||||
| Free Cash Flow | $ -1.16M | $ -971.50K | $ -1.21M | $ -828.26K | $ -1.77M |
| Operating Cash Flow | $ -1.16M | $ -971.50K | $ -1.21M | $ -828.26K | $ -1.77M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 781.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 1.61M | $ 570.36K | $ 315.90K | $ 963.77K | $ 677.00 |
Currency in GBP